Associate Professor William Herrington is an MRC-Kidney Research UK Professor David Kerr Clinician Scientist based at the Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford and Honorary Consultant Nephrologist at Oxford Kidney Unit. He is Chief Investigator of the EMPA-KIDNEY trial, and previously worked on the the SHARP, 3C and UK-HARP3 trials. https://www.ndph.ox.ac.uk/team/will-herringtonHe chairs the UK Renal Trial Network, was scientific coordinator of the KDIGO Controversies Conference on Challenges in the Conduct of Clinical Trials in Nephrology, and was a member of the ISN Working Group for the Consensus Definitions of Kidney Failure in Clinical Trials.
30 MARCH 2023
Time |
Session |
|
08:30
10:30
|
Hong Zhang
Chairperson
Peking University First HospitalChina
-
Fundamentals of Clinical Trials
-
Q and A
-
Core Statistics for Trials
-
Q and A
-
How Can Your Patient Co-design Your Trial?
-
Q and A
MR 110
|